- About
- Strategic Plan
- Structure
- Governance
- Scientific divisions
- ACRF Cancer Biology and Stem Cells
- ACRF Chemical Biology
- Advanced Technology and Biology
- Bioinformatics
- Blood Cells and Blood Cancer
- Clinical Translation
- Epigenetics and Development
- Immunology
- Infectious Diseases and Immune Defence
- Inflammation
- Personalised Oncology
- Population Health and Immunity
- Structural Biology
- Ubiquitin Signalling
- Laboratory operations
- Funding
- Annual reports
- Human research ethics
- Scientific integrity
- Institute life
- Career opportunities
- Business Development
- Partnering opportunities
- A complete cure for HBV
- A stable efficacious Toxoplasma vaccine
- Activating SMCHD1 to treat FSHD
- Improving vision outcomes in retinal detachment
- Intercepting inflammation with RIPK2 inhibitors
- Novel inhibitors for the treatment of lupus
- Novel malaria vaccine
- Precision epigenetics silencing SMCHD1 to treat Prader Willi Syndrome
- Rethinking CD52 a therapy for autoimmune disease
- Targeting minor class splicing
- Royalties distribution
- Start-up companies
- Partnering opportunities
- Collaborators
- Publications repository
- Awards
- Discoveries
- Centenary 2015
- History
- Contact us
- Research
- Diseases
- Cancer
- Development and ageing
- Immune health and infection
- Research fields
- Research technologies
- People
- Anne-Laure Puaux
- Associate Profesor Ian Majewski
- Associate Professor Aaron Jex
- Associate Professor Alyssa Barry
- Associate Professor Andrew Webb
- Associate Professor Chris Tonkin
- Associate Professor Daniel Gray
- Associate Professor Diana Hansen
- Associate Professor Edwin Hawkins
- Associate Professor Emma Josefsson
- Associate Professor Ethan Goddard-Borger
- Associate Professor Grant Dewson
- Associate Professor Isabelle Lucet
- Associate Professor James Murphy
- Associate Professor James Vince
- Associate Professor Jason Tye-Din
- Associate Professor Jeanne Tie
- Associate Professor Jeff Babon
- Associate Professor Joan Heath
- Associate Professor Justin Boddey
- Associate Professor Kate Sutherland
- Associate Professor Leanne Robinson
- Associate Professor Marco Herold Marco Herold
- Associate Professor Marie-Liesse Asselin-Labat
- Associate Professor Matthew Ritchie
- Associate Professor Melissa Davis
- Associate Professor Misty Jenkins
- Associate Professor Nawaf Yassi
- Associate Professor Oliver Sieber
- Associate Professor Peter Czabotar
- Associate Professor Rachel Wong
- Associate Professor Rhys Allan
- Associate Professor Rosie Watson
- Associate Professor Ruth Kluck
- Associate Professor Sandra Nicholson
- Associate Professor Sant-Rayn Pasricha
- Associate Professor Seth Masters
- Associate Professor Sumitra Ananda
- Associate Professor Tim Thomas
- Associate Professor Wai-Hong Tham
- Associate Professor Wei Shi
- Catherine Parker
- Chela Niall
- Deborah Carr
- Dr Alisa Glukhova
- Dr Anna Coussens
- Dr Ashley Ng
- Dr Ben Tran
- Dr Bernhard Lechtenberg
- Dr Brad Sleebs
- Dr Drew Berry
- Dr Gemma Kelly
- Dr Gwo Yaw Ho
- Dr Hui-Li Wong
- Dr Jacqui Gulbis
- Dr Joanna Groom
- Dr John Wentworth
- Dr Kelly Rogers
- Dr Lucy Gately
- Dr Margaret Lee
- Dr Mary Ann Anderson
- Dr Maryam Rashidi
- Dr Matthew Call
- Dr Melissa Call
- Dr Philippe Bouillet
- Dr Rebecca Feltham
- Dr Samir Taoudi
- Dr Shalin Naik
- Dr Sheau Wen Lok
- Dr Simon Chatfield
- Dr Tracy Putoczki
- Guillaume Lessene
- Helene Martin
- Joh Kirby
- Kaye Wycherley
- Keely Bumsted O'Brien
- Mr Joel Chibert
- Mr Simon Monard
- Mr Steve Droste
- Ms Carolyn MacDonald
- Professor Alan Cowman
- Professor Andreas Strasser
- Professor Andrew Lew
- Professor Andrew Roberts
- Professor Anne Voss
- Professor Clare Scott
- Professor David Huang
- Professor David Komander
- Professor David Vaux
- Professor Doug Hilton
- Professor Gabrielle Belz
- Professor Geoff Lindeman
- Professor Gordon Smyth
- Professor Ian Wicks
- Professor Ivo Mueller
- Professor Jane Visvader
- Professor Jerry Adams
- Professor John Silke
- Professor Ken Shortman
- Professor Leonard C Harrison
- Professor Lynn Corcoran
- Professor Marc Pellegrini
- Professor Marnie Blewitt
- Professor Melanie Bahlo
- Professor Mike Lawrence
- Professor Nicos Nicola
- Professor Peter Colman
- Professor Peter Gibbs
- Professor Phil Hodgkin
- Professor Stephen Nutt
- Professor Suzanne Cory
- Professor Terry Speed
- Professor Tony Burgess
- Professor Tony Papenfuss
- Professor Warren Alexander
- Diseases
- Education
- PhD
- Honours
- Masters
- Undergraduate
- Student research projects
- A new regulator of stemness to create dendritic cell factories for immunotherapy
- Advanced methods for genomic rearrangement detection
- Control of cytokine signaling by SOCS1
- Defining the protein modifications associated with respiratory disease
- Delineating the pathways driving cancer development and therapy resistance
- Developing a new drug that targets plasmacytoid dendritic cells for the treatment of lupus
- Development and mechanism of action of novel antimalarials
- Development of a novel particle-based malaria vaccine
- Development of tau-specific therapeutic and diagnostic antibodies
- Discovering novel therapies for major human pathogens
- Dissecting host cell invasion by the diarrhoeal pathogen Cryptosporidium
- Epigenetic biomarkers of tuberculosis infection
- Essential role of glycobiology in malaria parasites
- Evolution of haematopoiesis in vertebrates
- Human lung protective immunity to tuberculosis
- Identifying novel treatment options for ovarian carcinosarcoma
- Interaction with Toxoplasma parasites and the brain
- Interactions between tumour cells and their microenvironment in non-small cell lung cancer
- Investigating the role of mutant p53 in cancer
- Microbiome strain-level analysis using long read sequencing
- Minimising rheumatic adverse events of checkpoint inhibitor cancer therapy
- Modelling spatial and demographic heterogeneity of malaria transmission risk
- Naturally acquired immune response to malaria parasites
- Predicting the effect of non-coding structural variants in cancer
- Structural basis of catenin-independent Wnt signalling
- Structure and biology of proteins essential for Toxoplasma parasite invasion
- T lymphocytes: how memories are made
- TICKER: A cell history recorder for longitudinal patient monitoring
- Targeting host pathways to develop new broad-spectrum antiviral drugs
- Targeting post-translational modifications to disrupting the function of secreted proteins
- Targeting the epigenome to rewire pro-allergic T cells
- Targeting the immune microenvironment to treat KRAS-mutant adenocarcinoma
- The E3 ubiquitin ligase Parkin and mitophagy in Parkinson’s disease
- The molecular controls on dendritic cell development
- Understanding malaria infection dynamics
- Understanding the genetics of neutrophil maturation
- Understanding the neuroimmune regulation of innate immunity
- Understanding the proteins that regulate programmed cell death at the molecular level
- Using cutting-edge single cell tools to understand the origins of cancer
- When healthy cells turn bad: how immune responses can transition to lymphoma
- School resources
- Frequently asked questions
- Student profiles
- Abebe Fola
- Andrew Baldi
- Anna Gabrielyan
- Bridget Dorizzi
- Casey Ah-Cann
- Catia Pierotti
- Emma Nolan
- Huon Wong
- Jing Deng
- Joy Liu
- Kaiseal Sarson-Lawrence
- Komal Patel
- Lilly Backshell
- Megan Kent
- Naomi Jones
- Rebecca Delconte
- Roberto Bonelli
- Rune Larsen
- Runyu Mao
- Sarah Garner
- Simona Seizova
- Wayne Cawthorne
- Wil Lehmann
- Miles Horton
- Alexandra Gurzau
- Student achievements
- Student association
- News
- Donate
- Online donation
- Ways to support
- Support outcomes
- Supporter stories
- Rotarians against breast cancer
- A partnership to improve treatments for cancer patients
- 20 years of cancer research support from the Helpman family
- A generous gift from a cancer survivor
- A gift to support excellence in Australian medical research
- An enduring friendship
- Anonymous donor helps bridge the 'valley of death'
- Renewed support for HIV eradication project
- Searching for solutions to muscular dystrophy
- Supporting research into better treatments for colon cancer
- Taking a single cell focus with the DROP-seq
- WEHI.TV
Haematology

Abnormal production and function of blood cells underlies many human diseases.
Our haematology research seeks to understand blood cell formation and function in health and disease in order to develop better treatments for blood disorders.
Haematology research at the Institute
Our haematology researchers:
- Define molecules controlling blood cell development and function.
- Identify how blood cell abnormalities lead to diseases such as leukaemia, lymphoma, myeloproliferative disorders and myelodysplasia.
- Identify new strategies to treat blood diseases.
What is haematology?
Haematology is the study of blood and blood cell production and function in health and disease.
Healthy blood is composed of blood cells and the plasma (liquid) in which they circulate. There are three main cellular components of blood:
- Red cells, which carry oxygen and are the most numerous cells in blood.
- Platelets, tiny cells that coordinate the control of bleeding
- White cells, which fight infections.
Nearly half the volume of our blood is made of blood cells with the rest being plasma.
Plasma is the solution that carries our blood cells around our body. Dissolved proteins in plasma also have many important functions. These include:
- Maintaining the right amount of water in our blood, by preventing it from leaking out of our blood vessels.
- Fighting infection (through immune proteins called antibodies).
- Binding and carrying nutrients to cells and removing waste products.
- Carrying signals (hormones) around the body.
- Allowing blood clots to form in close collaboration with blood platelets when bleeding occurs.
Defects in blood cells or plasma proteins can be associated with many human diseases.
How are blood cells formed?
In an adult, blood cells are produced by stem cells in the bone marrow. One blood stem cell can produce all the blood cells in our system.
Progenitor cells develop from stem cells. They expand and mature, becoming much more specialised in their functions while becoming limited in the types of mature blood cells they produce. The two main types of progenitor cells are:
- Lymphoid progenitor cells, which develop into white blood cells called lymphocytes and other cells involved in the adaptive (specialised) immune system.
- Myeloid progenitor cells, which develop into non-lymphocyte white blood cells such as neutrophils, as well as red blood cells, and megakaryocytes (which form platelets).
All blood cells start with the same genetic code (genome), but as the cells develop, different genes switch on and off. This highly regulated process controls the protein machinery a blood cell makes and, ultimately, how a blood cell behaves and functions.
This highly regulated switching on and off of specific blood cell genes explains how different blood cells have vastly different functions within the body.
Our researchers have identified a detailed ‘road map’ of gene expression in blood cells which maps out which genes are turned on or off at every stage of blood cell development.
Colony stimulating factors
The growth, survival and function of blood cells are critically controlled by proteins, called cytokines, that are dissolved in the plasma. A large number of cytokines regulate a cell’s decision to become one blood cell type or another. Cytokines also regulate cells’ responses to emergencies such as bleeding or infection.
One particularly important class of cytokines involved in blood cell development is the colony stimulating factors. Colony stimulating factors (CSFs) were discovered at the Walter and Eliza Hall Institute by Professor Donald Metcalf in collaboration with Dr Ray Bradley from The University of Melbourne.
Colony stimulating factors have many functions including:
- Directing blood progenitors to form different types of white blood cells.
- Instructing blood cells to divide
- Regulating white blood cell function.
Colony stimulating factors are now used routinely to treat patients undergoing chemotherapy or in bone marrow transplantation.
Diseases of the blood
Abnormal blood cell production or function can cause many diseases. Understanding how these occur can lead to new strategies for treatment of these diseases.
Blood cell deficiencies
If too few blood cells are produced or excessive blood cells are lost, such as through bleeding, problems arise from the resultant blood cell deficiencies. These include:
- Anaemia, where too few red blood cells leads to problems such as tiredness, lethargy and blood circulation problems.
- Leukopenia, where too few white cells leads to immunodeficiency, increasing the risk of infection.
- Thrombocytopenia, where having too few platelets increases the risk of bleeding.
Blood cell cancers
The production of too many blood cells or uncontrolled growth of abnormal blood cells is the basis of blood cancers.
- Leukaemias are diseases in which an abnormal number of immature blood cells are produced in the bone marrow and can be detected circulating in the blood.
- Lymphomas are diseases in which abnormal lymphocytes grow, causing swelling of lymphocyte-containing tissues such as the lymph nodes or spleen.
- Myeloproliferative diseases, a range of conditions in which too many mature blood cells are produced. This leads to problems with blood circulation, and an increased risk of developing an aggressive leukaemia.
Blood clotting problems
Bleeding occurs when there is a breach of a blood vessel. Blood clotting is the important response creating a clot that plugs the wound to stop the blood vessel from bleeding. Clots are composed of:
- Platelets, which initiate and coordinate blood clotting.
- Clotting factors, which are soluble proteins in the blood that are converted into an ‘insoluble’ fibrin mesh to stabilise a blood clot.
Within a clot, platelets are critical for sending signals and triggering clot formation and wound repair. Some of these signals may also attract immune cells to the injured area, and instruct them to be ready to fight potential infection.
Several diseases are associated with problems of platelets or clotting factors.
Deficiencies or abnormalities in the function of platelets or clotting factors can lead to excessive bleeding. Examples of this include:
- Thrombocytopaenia, meaning a lack of platelets, can predispose to excessive bleeding.
- Haemophilia, in which a particular clotting factor is not produced, impeding clot formation.
Excessive numbers of platelets or an imbalance of clotting and anti-clotting factors can cause blood clots to form and block blood vessels to critical organs.
Some diseases that involve problems with blood clotting include:
- Essential thrombocythemia, a myeloproliferative disease, in which too many platelets are produced, causing a tendency to excessive clotting.
- Thrombophilia, in which an imbalance of clotting and anti-clotting proteins creates a predisposition to clot formation.
- Stroke, in which a blood clot can block the blood supply to the brain.
- Acute myocardial infarction (heart attack), in which a blood clot blocks supply to a heart blood vessel.
Blood donation and blood stem cell transplantation
Several blood cell deficiencies (such as anaemia, thrombocytopenia, and, occasionally, leukopenia) and blood clotting disorders (such as haemophilia) can be treated by replacing the missing blood component.
In all situations requiring blood cell replacement, the missing blood component comes from healthy volunteer donors. Missing plasma protein components can also be replaced by plasma from healthy volunteer donors. Recently genetic technology has been used to produce particular blood proteins.
In circumstances where a patient’s bone marrow stem cells need to be replaced, a specialised medical procedure called a bone marrow transplant can be undertaken. This replaces the bone marrow of the patient (bone marrow transplant recipient) with the stem cells that had been previously collected from the patient, or from a volunteer donor (bone marrow donor).
Haematologists are doctors who specialise in blood disorders and blood disease therapy.
Researchers:
Our researchers have discovered how an essential blood-making hormone stimulates platelet production
Animation explaining how DNA changes lead to the blood disease sickle cell anaemia
Our research has resolved a longstanding debate about the formation of platelets, tiny cells that allow blood to clot.
Professor Andrew Roberts discusses the results of a clinical trial of a potential new anti-cancer agent on ABC Radio.